Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01186003
Recruitment Status : Completed
First Posted : August 20, 2010
Last Update Posted : July 26, 2018
Novo Nordisk A/S
Information provided by (Responsible Party):
University of Colorado, Denver

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2017
  Actual Study Completion Date : October 2017